Pneumococcal Conjugate Vaccine (PCV) Schedules for the Northern Territory (NT): Randomised Controlled Trial of Booster Vaccines to Broaden and Strengthen Protection From Invasive and Mucosal Infections.
Phase of Trial: Phase IV
Latest Information Update: 14 Jan 2013
At a glance
- Drugs Haemophilus influenzae-pneumococcal vaccine (Primary) ; Pneumococcal 13-valent CRM197 vaccine conjugate (Primary)
- Indications Otitis media; Pneumococcal infections; Respiratory tract infections
- Focus Therapeutic Use
- Acronyms PREV-IX_BOOST
- 14 Jan 2013 Planned End Date changed from 1 Dec 2016 to 1 Dec 2017 as reported by ClinicalTrials.gov.
- 05 Jan 2013 New trial record